We are live on ! Find out more
HLTH

Cue Health Inc. Common Stock

Delisted

HLTH was delisted on the 5th of June, 2024.

96 hedge funds and large institutions have $157M invested in Cue Health Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

518% more call options, than puts

Call options by funds: $1.22M | Put options by funds: $197K

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

20% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 25

3% more funds holding

Funds holding: 9396 (+3)

22% less capital invested

Capital invested by funds: $203M → $157M (-$45.5M)

Holders
96
Holders Change
+3
Holders Change %
+3.23%
% of All Funds
1.54%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.1%
New
11
Increased
30
Reduced
25
Closed
8
Calls
$1.22M
Puts
$197K
Net Calls
+$1.02M
Net Calls Change
-$299K
Name Holding Trade Value Shares
Change
Change in
Stake
KI
1
Koch Industries
Kansas
$27.3M
OC
2
Oakmont Corp
California
$19.9M
DCMIC
3
Decheng Capital Management III (Cayman)
Cayman Islands
$18.6M
MA
4
Madrone Advisors
California
$14.7M +$22.4M +7,078,566 New
BlackRock
5
BlackRock
New York
$14.1M +$719K +227,471 +3%
JJ
6
Johnson & Johnson
New Jersey
$11.5M
JPC
7
Jabodon PT Co
Nevada
$9.47M
Vanguard Group
8
Vanguard Group
Pennsylvania
$8.94M +$893K +282,633 +7%
Temasek Holdings
9
Temasek Holdings
Singapore
$6.47M
State Street
10
State Street
Massachusetts
$4.4M +$1.51M +476,796 +29%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$3.97M +$142K +45,027 +2%
BL
12
Bleichroeder LP
New York
$2.07M
Northern Trust
13
Northern Trust
Illinois
$1.85M +$127K +40,153 +5%
Goldman Sachs
14
Goldman Sachs
New York
$1.46M -$607K -192,267 -21%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$879K -$317K -100,248 -19%
MP
16
MSD Partners
New York
$818K
N
17
Nuveen
North Carolina
$714K -$126K -40,035 -10%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$707K +$60.6K +19,179 +6%
JP Morgan Chase
19
JP Morgan Chase
New York
$651K +$154K +48,617 +18%
AQR Capital Management
20
AQR Capital Management
Connecticut
$602K +$919K +290,870 New
Charles Schwab
21
Charles Schwab
California
$589K -$28 -9 -0%
Janney Montgomery Scott
22
Janney Montgomery Scott
Pennsylvania
$447K +$430K +136,100 +171%
Mirae Asset Global Investments
23
Mirae Asset Global Investments
South Korea
$435K -$99K -31,342 -13%
Renaissance Technologies
24
Renaissance Technologies
New York
$431K +$23.7K +7,500 +4%
AFM
25
Anson Funds Management
Texas
$421K +$643K +203,414 New

HLTH Hedge Fund Activity: Q4 2022 in Review

96 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cue Health Inc. Common Stock (HLTH) for Q4 2022, worth a combined $157M — down 22% from $203M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new HLTH positions and 8 closed out — a net gain of 3 holders — while 30 added to existing stakes and 25 trimmed.

The largest buyer was State Street, adding an estimated $1.51M. The largest seller was Janus Henderson Group, cutting an estimated $629K.

  • 96 institutional investors held Cue Health Inc. Common Stock (HLTH) as of Q4 2022, up from 93 in Q3 2022.
  • Funds reported $157M of Cue Health Inc. Common Stock stock for Q4 2022, down 22% quarter-over-quarter.
  • 11 funds opened new Cue Health Inc. Common Stock positions in Q4 2022 and 8 closed out, a net change of +3 holders.
  • The largest Cue Health Inc. Common Stock buyer in Q4 2022 was State Street, an estimated $1.51M added.
  • The largest Cue Health Inc. Common Stock seller in Q4 2022 was Janus Henderson Group, an estimated $629K sold.

Based on aggregated 13F filings for Q4 2022.